[175 Pages Report] Single-cell Analysis Market is estimated to grow at a CAGR of 16.5% during the forecast period, to reach $ 3.59 billion
Technological advancements in single-cell analysis products, increasing government funding for cell-based research, growing biotechnology and biopharmaceutical industries, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine, and increasing incidence and prevalence of chronic and infectious diseases are the major factors driving the growth of the market.
The objectives of this study are as follows:
– To define, describe, and forecast the market on the basis of products, cell type, technique, application, end user, and region.
– To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
– To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the market
-To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
– To forecast the size of market segments with respect to four regions, namely, North America, Europe, Asia, and the Rest of the World (RoW)
Browse and in-depth TOC on “Single-cell Analysis Market”.
107 — Tables
42 — Figures
175 — Pages
Single-cell Analysis Market, By Technique
Flow Cytometry
NGS
PCR
Microscopy
Mass Spectrometry
Single-cell Analysis Market, By Region:
North America
Europe
Asia
Rest of the World (RoW)
The Single-cell Analysis Market is highly fragmented in nature with several big as well as emerging players. Prominent players in this market include Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Promega Corporation (U.S.), Danaher Corporation (U.S.), General Electric Company (U.K.), Thermo Fisher Scientific Inc. (U.S.)